Current Challenges of iPSC-Based Disease Modeling and Therapeutic Implications

Area of Science:

• Biomedical Research
• Regenerative Medicine
• Stem Cell Biology

Background:

• Induced pluripotent stem cells (iPSCs) have emerged as a powerful tool in biomedical research over the last decade.
• iPSCs have enabled significant advancements in understanding monogenic diseases at the cellular level.
• The development of iPSC-derived cell products is driving progress in personalized regenerative medicine.

Purpose of the Study:

• To critically review the progress of iPSC applications in biomedical research and regenerative medicine over the past decade.
• To summarize key advancements in iPSC-based disease modeling and cell replacement therapies.
• To identify current challenges hindering the full clinical and pharmacological potential of iPSCs.

Main Methods:

• Review of scientific literature and case examples from the past decade.
• Analysis of iPSC applications in disease modeling, drug discovery, and regenerative medicine.
• Evaluation of emerging technologies such as organoids, gene editing, AI, and high-throughput 'omics' in conjunction with iPSCs.

Main Results:

• iPSCs have been instrumental in unraveling novel pathological mechanisms for numerous monogenic diseases.
• iPSC-based disease modeling offers unprecedented opportunities for high-throughput drug discovery and safety pharmacology.
• Ongoing clinical trials demonstrate the potential of iPSC-derived cell products for therapeutic applications.

Conclusions:

• The past decade has seen remarkable progress in harnessing iPSCs for biomedical applications and regenerative medicine.
• Significant challenges remain in translating iPSC potential into widespread clinical and pharmacological use.
• Addressing these challenges is crucial for developing more effective and safer regenerative therapies.